MX2020004192A - Composiciones nutricionales densas en proteinas para su uso en el tratamiento y/o la prevencion de una afeccion relacionada con la perdida de masa y/o fuerza muscular. - Google Patents

Composiciones nutricionales densas en proteinas para su uso en el tratamiento y/o la prevencion de una afeccion relacionada con la perdida de masa y/o fuerza muscular.

Info

Publication number
MX2020004192A
MX2020004192A MX2020004192A MX2020004192A MX2020004192A MX 2020004192 A MX2020004192 A MX 2020004192A MX 2020004192 A MX2020004192 A MX 2020004192A MX 2020004192 A MX2020004192 A MX 2020004192A MX 2020004192 A MX2020004192 A MX 2020004192A
Authority
MX
Mexico
Prior art keywords
protein
loss
preventing
strength
muscle mass
Prior art date
Application number
MX2020004192A
Other languages
English (en)
Inventor
Pauline Elisabeth Antoinette Smulders
Renate Antonia Ganzevles
George Verlaan
Marieke Henriëtte Schoemaker
Original Assignee
Frieslandcampina Nederland Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Frieslandcampina Nederland Bv filed Critical Frieslandcampina Nederland Bv
Publication of MX2020004192A publication Critical patent/MX2020004192A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/04—Animal proteins
    • A23J3/08—Dairy proteins
    • A23J3/10—Casein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/14—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A23L29/035—Organic compounds containing oxygen as heteroatom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/29—Mineral substances, e.g. mineral oils or clays
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/316—Foods, ingredients or supplements having a functional effect on health having an effect on regeneration or building of ligaments or muscles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/54—Proteins
    • A23V2250/542—Animal Protein
    • A23V2250/5424—Dairy protein
    • A23V2250/54246—Casein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Pediatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invención se refiere al campo de las composiciones nutricionales líquidas densas en proteínas para su uso en el tratamiento y/o la prevención de una afección relacionada con la pérdida de masa y/o fuerza muscular. Se proporciona una composición líquida rica en proteínas tratada con calor que comprende al menos 10 g de proteína por cada 100 ml de la composición, en donde al menos un 40 % en peso de la proteína es caseína micelar y al menos un 10 % en peso de la proteína es proteína de suero lácteo hidrolizada que tiene un grado de hidrolización de al menos el 5 % y en donde la relación en peso de caseína micelar a proteína de suero lácteo hidrolizada se encuentra en el intervalo de 40:60 a 90:10, para su uso en uno cualquiera o más de los siguientes: a) prevenir o reducir la coagulación en el tracto gastrointestinal superior; b) aumentar la velocidad de vaciado gástrico; c) potenciar la digestión de proteínas; d) aumentar la concentración sérica en la sangre de aminoácidos esenciales libres, preferentemente leucina, en un sujeto.
MX2020004192A 2017-10-30 2018-10-30 Composiciones nutricionales densas en proteinas para su uso en el tratamiento y/o la prevencion de una afeccion relacionada con la perdida de masa y/o fuerza muscular. MX2020004192A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17199172 2017-10-30
PCT/EP2018/079633 WO2019086407A1 (en) 2017-10-30 2018-10-30 Protein-dense nutritional compositions for use in treating and/or preventing a condition linked to loss of muscle mass and/or strength

Publications (1)

Publication Number Publication Date
MX2020004192A true MX2020004192A (es) 2020-08-03

Family

ID=60409115

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020004192A MX2020004192A (es) 2017-10-30 2018-10-30 Composiciones nutricionales densas en proteinas para su uso en el tratamiento y/o la prevencion de una afeccion relacionada con la perdida de masa y/o fuerza muscular.

Country Status (10)

Country Link
US (1) US20200253239A1 (es)
EP (1) EP3703727A1 (es)
JP (1) JP2021501182A (es)
KR (1) KR20200079485A (es)
CN (1) CN111246872A (es)
AU (1) AU2018361465A1 (es)
BR (1) BR112020008466A2 (es)
MX (1) MX2020004192A (es)
SG (1) SG11202001965PA (es)
WO (1) WO2019086407A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121337022A (zh) 2018-11-20 2026-01-16 方塔拉合作集团有限公司 乳制品产品和方法
WO2022089732A1 (en) * 2020-10-27 2022-05-05 N.V. Nutricia Native whey protein composition for improving gastro-intestinal tolerance
EP4326091A1 (en) * 2021-04-19 2024-02-28 Abbott Laboratories High protein liquid nutritional compositions
CN115530283B (zh) * 2022-09-29 2024-01-26 黑龙江飞鹤乳业有限公司 蛋白组合物
KR20240104311A (ko) 2022-12-27 2024-07-05 충남대학교병원 악액질을 동반한 암환자의 영양불량 예방 또는 영양상태 회복 촉진용 식품 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871768A (en) 1984-07-12 1989-10-03 New England Deaconess Hospital Corporation Dietary supplement utilizing ω-3/medium chain trigylceride mixtures
US6013665A (en) 1997-12-16 2000-01-11 Abbott Laboratories Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides
BRPI0820952B1 (pt) 2007-12-05 2018-01-16 N.V. Nutricia Composição nutricional enteral líquida tratada termicamente, uso da composição da mesma, e, uso simultâneo ou sequencial de caseína micelar e caseinato
RU2471371C2 (ru) * 2007-12-05 2013-01-10 Н.В. Нютрисиа Обогащенная белком жидкая энтеральная питательная композиция на основе мицеллярного казеина
CA2740911C (en) 2008-10-17 2014-07-29 Nestec S.A. Whey protein compositions, methods and uses
WO2010047581A1 (en) * 2008-10-24 2010-04-29 N.V. Nutricia Liquid high-fat protein composition
CA2792396C (en) 2010-03-12 2018-09-11 Nestec S.A. Compositions for masking the flavor of nutrients and methods for making same
NL2007268C2 (en) 2011-08-16 2013-02-19 Friesland Brands Bv Nutritional compositions comprising human milk oligosaccharides and uses thereof.
HUE050010T2 (hu) 2012-03-09 2020-11-30 Fonterra Cooperative Group Ltd Kazein készítmények alkalmazása
HK1214477A1 (zh) 2012-12-18 2016-07-29 Abbott Laboratories 低粘度、高热量密度的口服营养组合物和相关方法
ES2837050T3 (es) * 2015-10-01 2021-06-29 Frieslandcampina Nederland Bv Composición nutricional líquida que comprende caseína micelar y proteína de suero de leche hidrolizada

Also Published As

Publication number Publication date
BR112020008466A2 (pt) 2020-10-06
AU2018361465A1 (en) 2020-03-12
SG11202001965PA (en) 2020-04-29
WO2019086407A1 (en) 2019-05-09
CN111246872A (zh) 2020-06-05
KR20200079485A (ko) 2020-07-03
JP2021501182A (ja) 2021-01-14
EP3703727A1 (en) 2020-09-09
US20200253239A1 (en) 2020-08-13

Similar Documents

Publication Publication Date Title
MX2020004192A (es) Composiciones nutricionales densas en proteinas para su uso en el tratamiento y/o la prevencion de una afeccion relacionada con la perdida de masa y/o fuerza muscular.
Yang et al. Effective treatment of hypertension by recombinant Lactobacillus plantarum expressing angiotensin converting enzyme inhibitory peptide
WO2012081982A3 (en) Whey protein composition with a reduced astringency
RU2017101436A (ru) Mic-1 слитные белки и их применение
BR112012027055A2 (pt) agente estabilizante para proteínas farmacêuticas.
EP2532365A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF CANCER
EP2532366A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF CANCER
BRPI1010830A2 (pt) Sequências de aminoácidos melhoradas direcionadas contra o vírus respiratório sencicial humano (hrsv) e polipetídeos que compreende os mesmos para prevenção e/ou tratamento de infecções do trato respiratório.
JP2017528419A5 (es)
ATE544461T1 (de) Rekonstituierte tenside mit verbesserten eigenschaften
MX2021005925A (es) Proceso y producto lacteo.
CL2019001379A1 (es) Un método para producir un concentrado lácteo con agregación de proteínas de cationes divalentes libres.
DK1709069T3 (da) Produkt til behandling af halitosis
EA202192925A1 (ru) Твердые формы ингибитора glyt1
Gu et al. Novel extraction technologies and potential applications of egg yolk proteins
JP2017519763A5 (es)
Pang et al. Sarcopenia and nonalcoholic fatty liver disease: New evidence for low vitamin D status contributing to the link
Harris et al. Anionic antimicrobial peptides from eukaryotic organisms and their mechanisms of action
FR2870126A1 (fr) Vecteur lentiviral recombinant d'expression d'une proteine de flaviviridae et ses applications comme vaccin
ATE552271T1 (de) Antitumorarzneimittel, medikament, zusammensetzung und anwendung davon
JOP20240271A1 (ar) ببتيدات إظهار أنشطة منع فقدان العضلات وتعزيز الكتلة العضلية واستخداماتها
Mejrhit et al. Effect of industrial processing on the IgE reactivity of three commonly consumed Moroccan fish species in Fez region
MX2018011133A (es) Composicion farmaceutica para el tratamiento y/o prevencion de cancer.
Mahendru et al. Role of goat milk and milk products in dengue fever
BR0318443A (pt) proteìnas solúveis em ácido de caseìna micelar